737693-57-1 Usage
Uses
Used in Organic Synthesis:
Bicyclo[2.2.1]heptane-1-carboxylic acid, 4-amino(9CI) is used as a building block in organic synthesis for the creation of more complex organic molecules. Its unique bicyclic structure and functional groups allow for various chemical reactions and modifications, contributing to the development of novel compounds with potential applications in different fields.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, Bicyclo[2.2.1]heptane-1-carboxylic acid, 4-amino(9CI) serves as a starting material for the synthesis of pharmaceutical drugs. Its carboxylic acid and amino groups can be utilized in the formation of drug candidates, potentially leading to the discovery of new therapeutic agents with improved efficacy and selectivity.
However, it is important to note that further research and evaluation of the properties and potential uses of Bicyclo[2.2.1]heptane-1-carboxylic acid, 4-amino(9CI) are necessary to fully understand its capabilities and harness its potential in these applications.
Check Digit Verification of cas no
The CAS Registry Mumber 737693-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,7,6,9 and 3 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 737693-57:
(8*7)+(7*3)+(6*7)+(5*6)+(4*9)+(3*3)+(2*5)+(1*7)=211
211 % 10 = 1
So 737693-57-1 is a valid CAS Registry Number.
737693-57-1Relevant academic research and scientific papers
SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
Page/Page column 182, (2012/11/07)
Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.
